CN1320354C - Method for analysizing amino acid - Google Patents
Method for analysizing amino acid Download PDFInfo
- Publication number
- CN1320354C CN1320354C CNB2005100144780A CN200510014478A CN1320354C CN 1320354 C CN1320354 C CN 1320354C CN B2005100144780 A CNB2005100144780 A CN B2005100144780A CN 200510014478 A CN200510014478 A CN 200510014478A CN 1320354 C CN1320354 C CN 1320354C
- Authority
- CN
- China
- Prior art keywords
- amino acid
- standard
- solution
- sample
- measured value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明涉及一种氨基酸的分析方法。在C18柱上,以pH2-3或6-7的磷酸三乙胺(TEAP)/乙腈(ACN)为流动相高效液相色谱分离氨基酸(AA)的2,4-二硝基氟苯(DNFB)衍生物。柱温35℃,360nm紫外检测。本发明使用磷酸三乙胺(TEAP)/乙腈(ACN)流动相,提高了分离结果的重现性。通过选择水相缓冲区间和在区间内微调pH值,使分析方法适用于不同品牌色谱柱和各种试样类型,解决了氨基酸混合物的分析,并给出准确的结果。本发明不需增加设备,即可适合于一般HPLC分析室采用。应用范围包括各种氨基酸的分析以及其它物质转化为氨基酸后的间接分析,还包括除氨基酸以外其它能与DNFB进行定量衍生反应物质的分析。The invention relates to an analysis method of amino acid. On C18 post, with the triethylamine phosphate (TEAP)/acetonitrile (ACN) of pH2-3 or 6-7 as mobile phase high performance liquid chromatography separation amino acid (AA) 2,4-dinitrofluorobenzene ( DNFB) derivatives. The column temperature is 35°C, and 360nm ultraviolet detection. The present invention uses triethylamine phosphate (TEAP)/acetonitrile (ACN) mobile phase to improve the reproducibility of separation results. By selecting the aqueous phase buffer and fine-tuning the pH value within the range, the analysis method is applicable to different brands of chromatographic columns and various sample types, which solves the analysis of amino acid mixtures and gives accurate results. The invention does not need to add equipment, and can be suitable for general HPLC analysis room. The scope of application includes the analysis of various amino acids and the indirect analysis of other substances converted into amino acids, as well as the analysis of substances other than amino acids that can be quantitatively derivatized with DNFB.
Description
技术领域technical field
本发明涉及氨基酸的分析方法,基于以磷酸三乙胺/乙腈为流动相反相分离氨基酸-2,4-二硝基氟苯衍生物,使用通常的高效液相色谱仪和色谱条件,不再需要其它的仪器配置,就可以完成各种氨基酸试样的分析,并给出准确的结果。The present invention relates to an analysis method for amino acids, based on the separation of amino acid-2,4-dinitrofluorobenzene derivatives using triethylamine phosphate/acetonitrile as the mobile reverse phase, using common high-performance liquid chromatography and chromatographic conditions, no longer need Other instrument configurations can complete the analysis of various amino acid samples and give accurate results.
背景技术Background technique
氨基酸(amino acid,AA)试样比较复杂,常见的AA有20多种,色谱分析方法必须有足够的选择性,以分辨试样中所要测定的AA。大多数AA对紫外光无明显的吸收,为了检测,最常用的手段是使AA分子中的氨基与衍生剂反应,生成具有紫外吸收或荧光性质的衍生物。Amino acid (amino acid, AA) samples are relatively complex, and there are more than 20 common AA. The chromatographic analysis method must have sufficient selectivity to distinguish the AA to be determined in the sample. Most AA has no obvious absorption to ultraviolet light. For detection, the most common method is to react the amino group in the AA molecule with a derivatizing agent to generate derivatives with ultraviolet absorption or fluorescence properties.
通常采用两种途径分析AA试样。一种是借助离子交换机理先使AA彼此分离,再用柱后衍生进行检测。这是一般AA分析仪所使用的办法。AA samples are generally analyzed in two ways. One is to separate AA from each other by means of ion exchange mechanism, and then use post-column derivatization for detection. This is the approach used by general AA analyzers.
另一途径是,AA经柱前衍生后,以反相色谱分离AA的衍生物。柱前衍生法分离对仪器设备没有特殊的要求,同时采用反相分离模式,但要求衍生反应能使每种AA几乎完全地生成相应的特定产物,且有足够的检测灵敏度[朱彭龄、云自厚、谢光华,“现代液相色谱”,第22章,兰州大学出版社,1989]。Another approach is to separate AA derivatives by reverse phase chromatography after pre-column derivatization of AA. The pre-column derivatization separation has no special requirements on the equipment, while the reversed-phase separation mode is adopted, but it is required that the derivatization reaction can make each AA almost completely generate the corresponding specific product, and there is sufficient detection sensitivity [Zhu Pengling, Yun Zihou , Xie Guanghua, "Modern Liquid Chromatography", Chapter 22, Lanzhou University Press, 1989].
在早期的文献报道中,AA经2,4-二硝基氟苯(DNFB)柱前衍生,反相分离衍生物AA-DNFB,分离DNFB-AA是以60mM醋酸钠(pH=4.45)为水相,以甲醇为有机相,在C18柱上进行梯度洗脱[Morton R.C.;Gerber G.E.,Anal.Biochem.,170(1988)220.]。后来,大多使用pH=6.5-7的醋酸盐缓冲液-乙腈体系作为流动相,使异亮氨酸和亮氨酸之间有足够的分离度[Shang,Zhen-Hua;Yu,Yi-Nian;Guo,Wei;Jiang,Hui;Zhou,Liang-Mo,Chinese Journal of Chemistry,13(1995)163.]。In early literature reports, AA was derivatized by 2,4-dinitrofluorobenzene (DNFB) before the column, and the derivative AA-DNFB was separated by reverse phase. phase, with methanol as the organic phase, gradient elution was performed on a C 18 column [Morton RC; Gerber GE, Anal. Biochem., 170(1988) 220.]. Later, the acetate buffer-acetonitrile system with pH = 6.5-7 was mostly used as the mobile phase to achieve sufficient resolution between isoleucine and leucine [Shang, Zhen-Hua; Yu, Yi-Nian ; Guo, Wei; Jiang, Hui; Zhou, Liang-Mo, Chinese Journal of Chemistry, 13 (1995) 163.].
中国专利CN 1053128A公开了十八种复合氨基酸注射液的高效液相色谱分析方法,它以2,4-二硝基氟苯作衍生试剂,用柱前衍生化法对十八种复合氨基酸注射液进行定量测定。用定量稀释配制检测液,以一定浓度和pH值的流动相乙腈和流动相醋酸钠和醋酸缓冲液作梯度洗脱剂。Chinese patent CN 1053128A discloses a high-performance liquid chromatography analysis method for eighteen kinds of compound amino acid injections. It uses 2,4-dinitrofluorobenzene as a derivatization reagent, and uses a pre-column derivatization method to analyze eighteen kinds of compound amino acid injections. Perform quantitative measurements. The detection solution was prepared by quantitative dilution, and the mobile phase acetonitrile, mobile phase sodium acetate and acetate buffer with a certain concentration and pH value were used as gradient eluents.
实验表明,反相分离AA-DNFB对流动相pH值的变化很敏感,精确控制流动相pH值是至关重要的。当使用接近中性的醋酸盐溶液作为流动相的组分,一个明显的问题是,流动相的酸度远离该缓冲液的缓冲区间,此方法的耐用性(robustness)就得不到保证。不同日期配制的流动相和不同品牌,甚至同一品牌不同批号的色谱柱都可能影响DNFB-AA衍生物的色谱分离结果。Experiments showed that reversed-phase separation of AA-DNFB was sensitive to changes in mobile phase pH, and precise control of mobile phase pH was crucial. When using near-neutral acetate solution as a component of the mobile phase, an obvious problem is that the acidity of the mobile phase is far away from the buffer zone of the buffer, and the robustness of the method cannot be guaranteed. Mobile phases prepared on different dates and different brands, or even columns of the same brand with different batch numbers may affect the chromatographic separation results of DNFB-AA derivatives.
发明内容Contents of the invention
本发明的目的是提供一种氨基酸的分析方法。用磷酸三乙胺/乙腈为流动相反相分离氨基酸-2,4-二硝基氟苯衍生物,可以克服现有技术之不足。本发明以磷酸盐代替原有的醋酸盐,使用磷酸三乙胺(TEAP)/乙腈(ACN)流动相体系,提高了分离结果的重现性。本发明耐用性好,易于为一般实验室所采用。通过选择水相缓冲区间和在区间内微调pH值,使分析方法适用于不同品牌色谱柱和各种试样类型。不需增加设备,即可为一般HPLC分析室采用。The purpose of the present invention is to provide a method for analyzing amino acids. Using triethylamine phosphate/acetonitrile as the mobile reverse phase to separate amino acid-2,4-dinitrofluorobenzene derivatives can overcome the shortcomings of the prior art. The present invention replaces the original acetate with phosphate, and uses a triethylamine phosphate (TEAP)/acetonitrile (ACN) mobile phase system to improve the reproducibility of the separation result. The invention has good durability and is easy to be adopted in general laboratories. By selecting between aqueous phase buffers and fine-tuning the pH value within the range, the analysis method is applicable to different brands of chromatographic columns and various sample types. It can be used in general HPLC analysis room without additional equipment.
本发明氨基酸的分析方法包括:使用高效液相色谱仪,A经2,4-二硝基氟苯(DNFB)柱前衍生,反相分离衍生物AA-DNFB,以磷酸三乙胺/乙腈为流动相梯度洗脱或等度洗脱,在分析柱上反相分离氨基酸-2,4-二硝基氟苯衍生物,再用外标法定量分析计算出氨基酸的含量。The analysis method of amino acid of the present invention comprises: using high performance liquid chromatography, A is derivatized through 2,4-dinitrofluorobenzene (DNFB) before the column, reverse phase separation derivative AA-DNFB, with triethylamine phosphate/acetonitrile as Gradient elution or isocratic elution of the mobile phase, reverse-phase separation of amino acid-2,4-dinitrofluorobenzene derivatives on the analytical column, and quantitative analysis and calculation of the content of amino acids by external standard method.
本发明氨基酸的分析方法包括下述步骤:The analysis method of amino acid of the present invention comprises the following steps:
1)分别用HCl溶液作溶剂制备氨基酸标准溶液和试样溶液;1) using HCl solution as solvent to prepare amino acid standard solution and sample solution;
2)分别取标准溶液和试样溶液于为其体积10倍量的容量瓶中,加入0.5MNaHCO3,标准溶液或试样溶液与NaHCO3的体积比为1∶1;再加入1%2,4-二硝基氟苯的乙腈溶液,与标准溶液或试样溶液的体积比为0.5-1∶1,摇匀;置于60℃下加热60分钟,冷却至室温,用0.1MpH为6.5的磷酸盐缓冲液冲至刻度,摇匀,备用;2) Take the standard solution and the sample solution respectively in a
3)使用包括泵、混合器、恒温箱、紫外检测器以及工作站所组成的HPLC仪。在C18分析柱上,以的TEAP/ACN为流动相,梯度洗脱或等度洗脱分离AA-DNFB;色谱条件如下:3) Use an HPLC instrument comprising a pump, a mixer, an incubator, an ultraviolet detector and a workstation. On a C 18 analytical column, use TEAP/ACN as the mobile phase, gradient elution or isocratic elution to separate AA-DNFB; the chromatographic conditions are as follows:
分析柱 C18,5μm,250×4.6mmAnalytical column C 18 , 5μm, 250×4.6mm
流动相 A:ACN B:36mM TEAP,pH2-3或6-7Mobile phase A: ACN B: 36mM TEAP, pH2-3 or 6-7
洗脱方式 梯度洗脱或等度洗脱Elution mode Gradient elution or isocratic elution
检测 UV 300-380nm,Detect UV 300-380nm,
温度 20-45℃Temperature 20-45℃
4)用外标法定量分析计算4) Quantitative analysis and calculation with external standard method
试样中AA的浓度=(A试样/A标准)×C标准 The concentration of AA in the sample = (A sample /A standard ) × C standard
A试样:试样色谱图中AA的峰面积A sample : the peak area of AA in the sample chromatogram
A标准:标准色谱图中AA的峰面积A standard : the peak area of AA in the standard chromatogram
C标准:标准溶液AA的浓度。C standard : the concentration of standard solution AA.
本发明的具体实施方案包括下述步骤:Specific embodiments of the present invention include the following steps:
1)分别用0.1M HCl作溶剂制备AA标准溶液和试样溶液;1) Prepare AA standard solution and sample solution with 0.1M HCl as solvent respectively;
2)分别取1mL标准溶液和样品溶液于10mL棕色容量瓶中,加入1mL 0.5MNaHCO3,摇匀。再加入0.5-1mL 1% DNFB的乙腈溶液,摇匀;置于60℃下加热60分钟,冷却至室温,用0.1M pH为6.5的磷酸盐缓冲液冲至刻度,摇匀,备用。2) Take 1mL standard solution and sample solution respectively in a 10mL brown volumetric flask, add 1mL 0.5M NaHCO 3 , and shake well. Then add 0.5-1mL 1% DNFB in acetonitrile solution, shake well; heat at 60°C for 60 minutes, cool to room temperature, wash to the mark with 0.1M phosphate buffer solution with pH 6.5, shake well, and set aside.
3)使用包括泵、混合器、恒温箱、紫外检测器以及工作站所组成的HPLC仪。在C18分析柱上,以的TEAP/ACN为流动相,梯度洗脱或等度洗脱分离AA-DNFB。色谱条件如下:3) Use an HPLC instrument comprising a pump, a mixer, an incubator, an ultraviolet detector and a workstation. On a C 18 analytical column, AA-DNFB was separated by gradient elution or isocratic elution with TEAP/ACN as mobile phase. The chromatographic conditions are as follows:
分析柱 C18,5μm,250×4.6mmAnalytical column C 18 , 5μm, 250×4.6mm
流动相 A:ACN B:36mM TEAP,pH 2-3或6-7Mobile phase A: ACN B: 36mM TEAP, pH 2-3 or 6-7
洗脱方式 梯度洗脱或等度洗脱Elution mode Gradient elution or isocratic elution
检测 UV 300-380nm,优选360nm,Detect UV 300-380nm, preferably 360nm,
温度 20-45℃,优选35℃;Temperature 20-45°C, preferably 35°C;
4)用外标法定量分析计算4) Quantitative analysis and calculation with external standard method
试样中AA的浓度=(A试样/A标准)×C标准 The concentration of AA in the sample = (A sample /A standard ) × C standard
A试样:试样色谱图中AA的峰面积A sample : the peak area of AA in the sample chromatogram
A标准:标准色谱图中AA的峰面积A standard : the peak area of AA in the standard chromatogram
C标准:标准溶液AA的浓度。C standard : the concentration of standard solution AA.
本发明采用了磷酸盐代替原有的醋酸盐,提高了方法的耐用性。在该缓冲体系中,三乙胺的阳离子作为磷酸根的对离子,而不是钾或钠离子。磷酸盐的缓冲区间是pH=2-3和6-8。在所述的AA分析方法中,以36mM磷酸三乙胺,pH=2-3和6-7水溶液/ACN流动相体系洗脱AA-DNFB(2,4-二硝基氟苯)。其次,流动相的酸度影响分离选择性,以不同pH的TEAP为水相,AA分离选择性显示很大的差异,这为优化色谱条件提供了方便。此外,三乙胺的加入可抑制固定相上残留硅羟基对分离的影响。The invention adopts phosphate to replace the original acetate, which improves the durability of the method. In this buffer system, the cation of triethylamine acts as the counterion of phosphate, rather than potassium or sodium ions. Phosphate buffers are between pH=2-3 and 6-8. In the described AA analysis method, AA-DNFB (2,4-dinitrofluorobenzene) was eluted with 36 mM triethylamine phosphate, pH=2-3 and 6-7 aqueous solution/ACN mobile phase system. Secondly, the acidity of the mobile phase affects the separation selectivity. With TEAP of different pH as the aqueous phase, the separation selectivity of AA shows great differences, which provides convenience for optimizing the chromatographic conditions. In addition, the addition of triethylamine can inhibit the influence of residual silanol on the stationary phase on the separation.
本发明使用磷酸三乙胺(TEAP)/乙腈(ACN)流动相,提高了分离结果的重现性。通过选择水相缓冲区间和在区间内微调pH值,使分析方法适用于不同品牌色谱柱和各种试样类型(例如:注射液类、或原料药中主要成分的测定等),解决了氨基酸混合物的分析,并给出准确的结果。本发明不需增加设备,即可适合于一般HPLC分析室采用。应用范围扩大,包括各种氨基酸的分析以及其它物质转化为氨基酸后的间接分析,还包括除氨基酸以外其它能与DNFB进行定量衍生反应物质的分析。The present invention uses triethylamine phosphate (TEAP)/acetonitrile (ACN) mobile phase to improve the reproducibility of separation results. By selecting the aqueous phase buffer and fine-tuning the pH value within the range, the analysis method is applicable to different brands of chromatographic columns and various sample types (for example: injections, or the determination of main components in raw materials, etc.), to solve the problem of amino acids Analysis of mixtures and gives accurate results. The invention does not need to add equipment, and can be suitable for general HPLC analysis room. The scope of application is expanded, including the analysis of various amino acids and the indirect analysis of other substances converted into amino acids, as well as the analysis of substances other than amino acids that can be quantitatively derivatized with DNFB.
附图说明Description of drawings
图1是以36mM TEAP,pH 6-7/ACN为流动相肾病注射液色谱图。Figure 1 is a chromatogram of kidney disease injection with 36mM TEAP, pH 6-7/ACN as the mobile phase.
图2是以36mM TEAP,pH 6-7/ACN为流动相肝病注射液色谱图。Figure 2 is a chromatogram of liver disease injection with 36mM TEAP, pH 6-7/ACN as the mobile phase.
图3是以36mM TEAP,pH 2-3/ACN为流动相肾病注射液色谱图。Figure 3 is a chromatogram of kidney disease injection with 36mM TEAP, pH 2-3/ACN as the mobile phase.
图4是以36mM TEAP,pH 2-3/ACN为流动相肝病注射液色谱图。Figure 4 is a chromatogram of liver disease injection with 36mM TEAP, pH 2-3/ACN as the mobile phase.
图5是以36mM TEAP,pH 2-3/ACN为流动相丙谷酰胺酸解液色谱图。Fig. 5 is with 36mM TEAP, pH 2-3/ACN is the mobile phase chromatogram of glutamic acid hydrolyzate.
图6是以36mM TEAP,pH 2-3/ACN为流动相苯丙氨酸色谱图。Fig. 6 is chromatogram of mobile phase phenylalanine with 36mM TEAP, pH 2-3/ACN.
具体实施方式Detailed ways
以下结合实施例进一步说明本发明。Below in conjunction with embodiment further illustrate the present invention.
实施例1 肾病注射液(Amino acid for renal insufficiency, Hoechst Marion Roussel公司生产)和肝病注射液(Amino acid preparation for hepaticinsufficiency, Hoechst Marion Roussel公司生产)中AA的分析Example 1 Analysis of AA in kidney disease injection (Amino acid for renal insufficiency, produced by Hoechst Marion Roussel Company) and liver disease injection (Amino acid preparation for hepatic insufficiency, produced by Hoechst Marion Roussel Company )
1.试剂1. Reagents
1.1.0.1M HCl 4mL盐酸与480mL水相混合。1.1.0.1M HCl 4mL hydrochloric acid mixed with 480mL water.
1.2.1%DNFB 1g DNFB溶于100mL乙腈中。1.2.1% DNFB 1g DNFB was dissolved in 100mL acetonitrile.
1.3.0.5M NaHCO3 2.1g NaHCO3溶于50mL水中。1.3.0.5M NaHCO 3 2.1g NaHCO 3 was dissolved in 50mL of water.
1.4.0.1M磷酸盐缓冲液,pH 6.5称1.74g K2HPO4溶于100mL水中得0.1MK2HPO4。称1.36g KH2PO4溶于100mL水中得0.1M KH2PO4。向0.1M KH2PO4中加0.1M K2HPO4至pH=6.5。1.4.0.1M phosphate buffer, pH 6.5 Weigh 1.74g K 2 HPO 4 dissolved in 100mL water to obtain 0.1M K 2 HPO 4 . Dissolve 1.36g KH 2 PO 4 in 100mL water to obtain 0.1M KH 2 PO 4 . To 0.1M KH2PO4 was added 0.1M K2HPO4 to pH = 6.5.
1.5.36mM磷酸三乙胺(TEAP),pH 2.75 在烧杯中取~950mL水,用移液管取5mL三乙胺加至其中。混合后,用磷酸调节pH值至2.75。将溶液转移到1000mL容量瓶中,用水冲至刻度。过滤后使用。1.5.36mM triethylamine phosphate (TEAP), pH 2.75 Take ~950mL water in a beaker, and add 5mL triethylamine to it with a pipette. After mixing, adjust the pH to 2.75 with phosphoric acid. Transfer the solution to a 1000mL volumetric flask and flush to the mark with water. Use after filtering.
1.6.36mM磷酸三乙胺(TEAP),pH 6.50 在烧杯中取~950mL水,用移液管取5mL三乙胺加至其中。混合后,用磷酸调节pH值至6.50。将溶液转移到1000mL容量瓶中,用水冲至刻度。过滤后使用。1.6.36mM triethylamine phosphate (TEAP), pH 6.50 Take ~950mL water in a beaker, and add 5mL triethylamine to it with a pipette. After mixing, adjust the pH to 6.50 with phosphoric acid. Transfer the solution to a 1000mL volumetric flask and flush to the mark with water. Use after filtering.
2.标准溶液的制备 按肾病注射液和肝病注射液的组成,精确称取AA参照物,以0.1M HCl作溶剂定容。用移液管取AA标准溶液5mL于25mL容量瓶中,以0.1M HCl冲至刻度,摇匀备用。2. Preparation of standard solution According to the composition of Kidney Disease Injection and Liver Disease Injection, accurately weigh AA reference substance, and use 0.1M HCl as solvent to make up the volume. Use a pipette to take 5mL of AA standard solution into a 25mL volumetric flask, flush to the mark with 0.1M HCl, shake well and set aside.
3.试样溶液的制备 用移液管取AA注射液样品1mL于25mL容量瓶中,以0.1M HCl冲至刻度,摇匀备用。3. Preparation of sample solution Use a pipette to take 1mL of AA injection sample into a 25mL volumetric flask, flush to the mark with 0.1M HCl, and shake well for later use.
4.标准溶液和试样溶液的衍生反应 用移液管取稀释后的AA标准溶液和样品溶液各1mL,分别置于10mL棕色容量瓶中,加入1mL 0.5M NaHCO3,摇匀,再加入1mL1%DNFB,摇匀。置于60℃加热块上加热60分钟。冷却后,用0.1M磷酸盐缓冲液(pH 6.5)冲至刻度,摇匀,准备HPLC分析用。4. Derivative reaction of standard solution and sample solution Use a pipette to take 1mL each of the diluted AA standard solution and sample solution, put them in a 10mL brown volumetric flask, add 1mL 0.5M NaHCO 3 , shake well, then add 1mL1 %DNFB, shake well. Place on a 60°C heating block and heat for 60 minutes. After cooling, flush to the mark with 0.1M phosphate buffer (pH 6.5), shake well, and prepare for HPLC analysis.
5.色谱条件5. Chromatographic conditions
5.1.测定天冬、谷、脯、丙、异亮、亮氨酸5.1. Determination of Asparagus, Gu, Preserved, C, Isoleucine and Leucine
分析柱 Kromasil C18,5μm,250×4.6mmAnalytical column Kromasil C 18 , 5μm, 250×4.6mm
流动相 A:ACN B:36mM TEAP,pH 6.50Mobile phase A: ACN B: 36mM TEAP, pH 6.50
梯度 83/71/68/10/10 B%[VB/(VA+VB)]at 0/10/25/30/35minGradient 83/71/68/10/10 B%[V B /(V A +V B )]at 0/10/25/30/35min
平衡时间 10minBalance time 10min
检测 UV 360nmDetection UV 360nm
温度 35℃
进样体积 20μLInjection volume 20μL
在此条件下得到如色谱图1(肾病注射液)和2(肝病注射液)的分离结果,出峰顺序为:天冬、谷、精、丝、苏和甘(与试剂峰重叠)、脯、丙、缬、蛋、异亮、亮、色、组、苯丙、赖、酪氨酸Under these conditions, the separation results shown in chromatograms 1 (Kenbing Injection) and 2 (Ganbing Injection) were obtained, and the order of peaks was asparagus, grain, essence, silk, Su and Gan (overlapped with reagent peaks), preserved , acrylic, valerian, egg, isoleucine, bright, color, group, phenylpropanoid, lysine, tyrosine
5.2.测定精、丝、苏、甘、组、蛋、缬、色、苯丙、赖、酪氨酸5.2. Determination of essence, silk, threonine, sweetness, group, egg, valerian, color, phenylpropanoid, lysine, tyrosine
分析柱 Kromasil C18,5μm,250×4.6mmAnalytical column Kromasil C 18 , 5μm, 250×4.6mm
流动相 A:ACN B:36mM TEAP,pH 2.75Mobile phase A: ACN B: 36mM TEAP, pH 2.75
梯度 78/60/35/10/10 B%[VB/(VA+VB)]at 0/20/30/35/40minGradient 78/60/35/10/10 B%[V B /(V A +V B )]at 0/20/30/35/40min
平衡时间 10minBalance time 10min
检测 UV 360nmDetection UV 360nm
温度 35℃
进样体积 20μLInjection volume 20μL
在此条件下得到如色谱图3(肾病注射液)和4(肝病注射液)的分离结果,出峰顺序为:精、丝、天冬、谷、苏、甘、丙、脯、组、蛋、缬、色、苯丙、亮+异亮、赖、酪氨酸。Under this condition, the separation results shown in chromatograms 3 (Kenbing Injection) and 4 (Ganbing Injection) were obtained, and the order of peaks was: essence, silk, asparagus, grain, Su, Gan, C, preserved, group, egg , Valerian, color, phenylpropanoid, leuc + isoleic, lysine, tyrosine.
6.计算6. Calculate
试样中AA的浓度=(A试样/A标准)×C标准 The concentration of AA in the sample = (A sample /A standard ) × C standard
A试样:试样色谱图中AA的峰面积A sample : the peak area of AA in the sample chromatogram
A标准:标准色谱图中AA的峰面积A standard : the peak area of AA in the standard chromatogram
C标准:标准溶液AA的浓度C standard : the concentration of standard solution AA
7.肾病注射液的分析结果、准确度、精密度7. Analytical results, accuracy and precision of kidney disease injection
这里以肾病注射液为例,给出方法的准确度和精密度。肝病注射液也给出相近的结果。Here, the accuracy and precision of the method are given by taking nephrotic injection as an example. Liver Disease Injection also gave similar results.
7.1.准确度:7.1. Accuracy:
表1准确度测定结果(%RSD,相对标准偏差)
对所有测试的AA,回收率都在100±1%范围内。The recoveries were within 100 ± 1% for all AAs tested.
7.2.精密度:7.2. Precision:
该方法有较高的精密度,中间精密度和重复性都不大于0.5%,以下是测定结果。The method has high precision, the intermediate precision and repeatability are not more than 0.5%, the following are the measurement results.
7.2.1.中间精密度:7.2.1. Intermediate precision:
表2:中间精密度测定结果
7.2.2.重复性:7.2.2. Repeatability:
表3:重复性测定结果(SD标准偏差)
实施例2 丙谷酰胺(L-丙氨酰-L-谷氨酰胺)原料药(天津天成制药有限公司生产)中主成分丙谷酰胺含量的测定Example 2 Determination of content of main component propylglutamine in the bulk drug (produced by Tianjin Tiancheng Pharmaceutical Co., Ltd.) of propylglutamine (L-alanyl-L-glutamine)
1.试剂1. Reagents
1.1. 参见实施例l。1.1. See embodiment 1.
1.2. 6N HCl 浓盐酸和水按1∶1(V/V)混合。1.2. Mix 6N HCl concentrated hydrochloric acid and water at a ratio of 1:1 (V/V).
2.标准溶液的制备 从干燥器中取出丙谷酰胺基准物,精确称取约15mg于带盖的聚乙烯管(1)中,用移液管加1mL 6N HCl,盖严,摇匀备用。2. Preparation of standard solution Take out the standard substance of Proglutamine from the desiccator, accurately weigh about 15mg into a polyethylene tube with a cover (1), add 1mL of 6N HCl with a pipette, cover tightly, and shake well for later use.
3.试样溶液的制备 精确称取丙谷酰胺试样约15mg于带盖的聚乙烯管(2)中,用移液管加1mL 6N HCl,盖严,摇匀备用。3. Preparation of sample solution Accurately weigh about 15 mg of proglutamine sample into a polyethylene tube with a cover (2), add 1 mL of 6N HCl with a pipette, cover tightly, and shake well for later use.
4.标准溶液和试样溶液的酸解 将聚乙烯管(1)和(2)于105℃加热6小。冷却,摇匀备用。4. Acid hydrolysis of standard solution and sample solution Heat polyethylene tubes (1) and (2) at 105°C for 6 hours. Let cool, shake well and set aside.
5.不经酸解试样溶液的制备 精确称取丙谷酰胺试样约15mg于带盖的聚乙烯管(3)中,用移液管加1mL水,盖严,摇匀备用。5. Preparation of sample solution without acid hydrolysis Accurately weigh about 15 mg of proglutamine sample into a polyethylene tube with a cover (3), add 1 mL of water with a pipette, cover tightly, and shake well for later use.
6.衍生反应 用移液管分别从聚乙烯管(1)、(2)和(3)吸取溶液各20L,置于10mL棕色容量瓶中。分别加1mL 0.5M NaHCO3,摇匀。再加0.5mL 1% DNFB,摇匀。将溶液置于加热块中,60℃加热60分钟,取出冷却。用0.1M磷酸盐缓冲液(pH 6.5)冲至刻度,摇匀,准备HPLC分析用。6. Derivatization reaction Use a pipette to draw 20L each of the solutions from polyethylene tubes (1), (2) and (3), and place them in a 10mL brown volumetric flask. Add 1mL 0.5M NaHCO 3 respectively and shake well. Add 0.5mL 1% DNFB and shake well. Place the solution in a heating block, heat at 60°C for 60 minutes, remove to cool. Rinse to the mark with 0.1M phosphate buffer (pH 6.5), shake well, and prepare for HPLC analysis.
7.色谱条件7. Chromatographic conditions
分析柱 Kromasil C18,5μm,250×4.6mmAnalytical column Kromasil C 18 , 5μm, 250×4.6mm
流动相 A:ACN B:36mM TEAP,pH2.75Mobile phase A: ACN B: 36mM TEAP, pH2.75
梯度 78/64.5/60/60B%[VB/(VA+VB)]at 0/15/25/30minGradient 78/64.5/60/60B%[V B /(V A +V B )]at 0/15/25/30min
平衡时间 10minBalance time 10min
检测 UV360nmDetection UV360nm
温度 35℃
进样体积 20μLInjection volume 20μL
在此条件下得到如色谱图5的分离结果。Under these conditions, the separation results as in
8.计算8. Calculate
8.1.当未酸解试样谱图中Ala-Glu、L-Glu衍生物的峰面积小于Ala-Gln衍生物峰面积的0.1%时,就不考虑这些杂质对测定的影响。8.1. When the peak area of Ala-Glu and L-Glu derivatives is less than 0.1% of the peak area of Ala-Gln derivatives in the chromatogram of the unacidified sample, the influence of these impurities on the determination is not considered.
丙谷酰胺的百分含量=[(A试样:×W标准)/(A标准×W试样)]×100%The percentage content of proglutamine=[(A sample :×W standard )/(A standard ×W sample )]×100%
W试样:酸解试样重(mg)W sample : acid hydrolysis sample weight (mg)
W标准:丙谷酰胺基准物重(mg)W standard : Proglutamine reference weight (mg)
A试样:酸解试样谱图中谷氨酸衍生物峰面积A sample : the peak area of glutamic acid derivatives in the spectrum of the acid hydrolyzed sample
A标准:基准物谱图中谷氨酸衍生物峰面积 Standard A: Peak area of glutamic acid derivatives in the spectrum of reference substances
8.2.当未酸解试样谱图中Ala-Glu、L-Glu的峰面积大于Ala-Gln峰面积的0.1%时,应校正丙谷酰胺的测定结果。丙谷酰胺在酸、碱、氧化剂存在下的降解实验结果表明,Ala-Glu是主要降解物,但没观察到L-Glu。因此,校正时主要考虑试样中原有的Ala-Glu。8.2. When the peak area of Ala-Glu and L-Glu in the chromatogram of the unacid-hydrolyzed sample is greater than 0.1% of the peak area of Ala-Gln, the determination result of proglutamine should be corrected. The degradation experiment results of proglutamine in the presence of acid, alkali and oxidant showed that Ala-Glu was the main degradation product, but no L-Glu was observed. Therefore, the original Ala-Glu in the sample is mainly considered during calibration.
丙谷酰胺的百分含量={[A试样×AAla-Gln×W标准]/[(AAla-Gln+AAla-Glu×f)×(A标准×W试样)]}×100%The percentage content of proglutamine={[A sample ×A Ala-Gln ×W standard ]/[(A Ala-Gln +A Ala-Glu ×f)×(A standard ×W sample )]}×100 %
W试样:酸解试样重(mg)W sample : acid hydrolysis sample weight (mg)
W标准:丙谷酰胺基准物重(mg)W standard : Proglutamine reference weight (mg)
A试样:酸解试样谱图中谷氨酸衍生物峰面积A sample : the peak area of glutamic acid derivatives in the spectrum of the acid hydrolyzed sample
A标准:基准物谱图中谷氨酸衍生物峰面积 Standard A: Peak area of glutamic acid derivatives in the spectrum of reference substances
AAla-Gln::未酸解试样谱图中丙谷酰胺衍生物的峰面积A Ala-Gln :: the peak area of the proglutamine derivative in the spectrum of the unacid-hydrolyzed sample
AAla-Glu::未酸解试样谱图中丙谷二肽衍生物的峰面积A Ala-Glu :: the peak area of the dipeptide derivative in the spectrum of the unacid-hydrolyzed sample
f:丙谷酰胺和丙谷二肽相对响应因子。f: Relative response factors of proglutamine and proglutamine.
实施例3 丙谷酰胺注射液(四川科伦药业股份有限公司生产)中丙谷酰胺含量的测定Example 3 Determination of Proglutamine Content in Proglutamine Injection (Sichuan Kelun Pharmaceutical Co., Ltd. Production)
1.试剂1. Reagents
1.1. 参见实施例1。1.1. See Example 1.
1.2. 6.7N HCl 167mL浓盐酸用水稀释到300mL。1.2. Dilute 6.7N HCl 167mL concentrated hydrochloric acid to 300mL with water.
2.标准溶液的制备 精确称取约20mg丙谷酰胺或13.5mg谷氨酸基准物于带盖的聚乙烯管(1)中,加100μL水和900μL 6.7N HCl,盖严,摇匀备用。2. Preparation of standard solution Accurately weigh about 20mg of proglutamine or 13.5mg of glutamic acid reference substance into a polyethylene tube with a cover (1), add 100μL of water and 900μL of 6.7N HCl, cover tightly, and shake well for later use.
3.试样溶液的制备 取100μL试样溶液和900μL 6.7N HCl于带盖的聚乙烯管(2)中,盖严,摇匀备用。3. Preparation of sample solution Take 100 μL of sample solution and 900 μL of 6.7N HCl in a polyethylene tube with a cover (2), cover it tightly, and shake well for later use.
4.酸解 将聚乙烯管(1)和(2)置于加热块中,105℃加热6小时后,取出冷却,摇匀备用。4. Acid hydrolysis Put the polyethylene tubes (1) and (2) in a heating block, heat at 105°C for 6 hours, take it out to cool, shake well and set aside.
5.衍生反应 用移液管分别吸取酸解标准溶液和试样溶液各20mL于10mL棕色容量瓶中。分别加1mL 0.5M NaHCO3,摇匀。再加0.5mL 1% DNFB,摇匀。将容量瓶置于加热块中,60℃加热60分钟,取出冷却。用0.1M磷酸盐缓冲液(pH 6.5)冲至刻度,摇匀,准备HPLC分析用。5. Derivatization reaction Use a pipette to draw 20mL each of the acid hydrolysis standard solution and the sample solution into a 10mL brown volumetric flask. Add 1mL 0.5M NaHCO 3 respectively and shake well. Add 0.5mL 1% DNFB and shake well. Place the volumetric flask in a heating block, heat at 60°C for 60 minutes, take it out and cool. Rinse to the mark with 0.1M phosphate buffer (pH 6.5), shake well, and prepare for HPLC analysis.
6.色谱条件6. Chromatographic conditions
分析柱 Kromasil C18,5μm,250×4.6mmAnalytical column Kromasil C 18 , 5μm, 250×4.6mm
流动相 A:ACN B:36mM TEAP,pH2.75Mobile phase A: ACN B: 36mM TEAP, pH2.75
梯度 78/64.5/60/60B%[VB/(VA+VB)]at 0/15/25/30minGradient 78/64.5/60/60B%[V B /(V A +V B )]at 0/15/25/30min
平衡时间 10minBalance time 10min
检测 UV360nmDetection UV360nm
温度 35℃
进样体积 20μLInjection volume 20μL
在此条件下得到如色谱图5的分离结果。Under these conditions, the separation results as in
7.计算7. Calculate
7.1.以丙谷酰胺为基准物时,丙谷酰胺的浓度按下试计算:7.1. When proglutamine is used as the reference substance, the concentration of proglutamine is calculated as follows:
丙谷酰胺的浓度(g/100mL)=A试样×C标准/A标准 Concentration of Proglutamine (g/100mL)=A sample ×C standard /A standard
C标准:丙谷酰胺基准物溶液浓度(以100L溶液中基准物称量计算,g/100mL)C standard : concentration of proglutamine reference substance solution (calculated by weighing the reference substance in 100L solution, g/100mL)
A试样:试样谱图中谷氨酸衍生物峰面积A sample : peak area of glutamic acid derivative in the sample spectrum
A标准:基准物谱图中谷氨酸衍生物峰面积 Standard A: Peak area of glutamic acid derivatives in the spectrum of reference substances
7.2.以谷氨酸为基准物时,丙谷酰胺的浓度按下试计算:7.2. When glutamic acid is used as the reference substance, the concentration of proglutamine is calculated as follows:
丙谷酰胺的浓度(g/100mL)=(A试样×C标准/A标准)×(MAla-Gln/ML-Glu)Proglutamine concentration (g/100mL) = (A sample × C standard / A standard ) × (M Ala-Gln / M L-Glu )
C标准:丙谷酰胺基准物溶液浓度(以100L溶液中基准物称量计算,g/100mL)C standard : concentration of proglutamine reference substance solution (calculated by weighing the reference substance in 100L solution, g/100mL)
A试样:试样谱图中谷氨酸衍生物峰面积A sample : peak area of glutamic acid derivative in the sample spectrum
A标准:基准物谱图中谷氨酸衍生物峰面积 Standard A: Peak area of glutamic acid derivatives in the spectrum of reference substances
MAla-Gln:丙谷酰胺摩尔量M Ala-Gln : molar amount of proglutamine
ML-Glu:谷氨酸摩尔量。M L-Glu : molar amount of glutamic acid.
实施例4 L-苯丙氨酸原料药中主成分苯丙氨酸含量的测定The determination of main component phenylalanine content in the embodiment 4 L-phenylalanine crude drug
1.试剂 参见实施例1。1. Reagents See Example 1.
2.标准溶液的制备 从干燥器中取出苯丙氨酸基准物,于100mL容量瓶中精确称取约20mg。以0.1M HCl为溶剂溶解并冲至刻度,摇匀。2. Preparation of standard solution Take out the phenylalanine reference substance from the desiccator, and accurately weigh about 20mg in a 100mL volumetric flask. Dissolve in 0.1M HCl as a solvent and rush to the mark, shake well.
3.试样溶液的制备 于100mL容量瓶中精确称取苯丙氨酸试样约20mg。以0.1MHCl为溶剂溶解并冲至刻度,摇匀。3. Preparation of sample solution Accurately weigh about 20 mg of phenylalanine sample in a 100 mL volumetric flask. Dissolve in 0.1M HCl as solvent and rush to the mark, shake well.
4.标准溶液和试样溶液的衍生反应 用移液管分别取标准溶液和样品溶液1mL,置于10mL容量瓶中,加入1mL 0.5M NaHCO3摇匀,再加0.5mL 1%DNFB,摇匀。4. Derivative reaction of standard solution and sample solution Take 1mL of standard solution and sample solution respectively with a pipette, put them in a 10mL volumetric flask, add 1mL 0.5M NaHCO 3 and shake well, then add 0.5mL 1% DNFB, shake well .
将溶液置于60℃水浴上加热60分钟,冷却。用0.1M磷酸盐缓冲液(pH 6.5)冲至刻度,摇匀,准备HPLC分析用。The solution was heated on a 60°C water bath for 60 minutes and cooled. Rinse to the mark with 0.1M phosphate buffer (pH 6.5), shake well, and prepare for HPLC analysis.
5.色谱条件5. Chromatographic conditions
分析柱 Alltima C18,5μm,250×4.6mmAnalytical column Alltima C 18 , 5μm, 250×4.6mm
流动相 ACN/36mM TEAP,pH2.75 体积比:48/52等度洗脱Mobile phase ACN/36mM TEAP, pH2.75 volume ratio: 48/52 isocratic elution
检测 UV 360nmDetection UV 360nm
温度 35℃
进样体积 20μLInjection volume 20μL
在此条件下得到如色谱图6的分离结果。Under these conditions, the separation results shown in chromatogram 6 were obtained.
6.计算6. Calculate
试样中的苯丙氨酸的百分含量=(A试样/A标准)×(W标准/W标准)×100%The percentage content of phenylalanine in the sample=(A sample /A standard )×(W standard /W standard )×100%
A试样:试样色谱图中苯丙氨酸的峰面积A sample : the peak area of phenylalanine in the sample chromatogram
A标准:标准色谱图中苯丙氨酸的峰面积A standard : the peak area of phenylalanine in the standard chromatogram
W标准:苯丙氨酸基准物的称量,mgW standard : weighing of phenylalanine reference substance, mg
W试样:苯丙氨酸基试样的称量,mg。W sample : the weight of the phenylalanine-based sample, mg.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100144780A CN1320354C (en) | 2005-07-14 | 2005-07-14 | Method for analysizing amino acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100144780A CN1320354C (en) | 2005-07-14 | 2005-07-14 | Method for analysizing amino acid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1749748A CN1749748A (en) | 2006-03-22 |
| CN1320354C true CN1320354C (en) | 2007-06-06 |
Family
ID=36605310
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100144780A Expired - Lifetime CN1320354C (en) | 2005-07-14 | 2005-07-14 | Method for analysizing amino acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1320354C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102702344A (en) * | 2012-06-14 | 2012-10-03 | 上海吉尔多肽有限公司 | Method for purifying tesamorelin |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101963603B (en) * | 2010-09-30 | 2013-04-24 | 湖北新生源生物工程股份有限公司 | Method for analyzing arginine and arginine hydrochloride raw materials and preparations by using HPLC method |
| CN102268073B (en) * | 2011-07-19 | 2013-06-05 | 南昌佰泰生物科技有限公司 | Method for preparing somatostatin |
| CN103969253B (en) * | 2013-07-23 | 2016-12-28 | 中国科学院烟台海岸带研究所 | A kind of simplicity quickly detects the method for L cysteine |
| CN105021740A (en) * | 2015-08-15 | 2015-11-04 | 杭州新博思生物医药有限公司 | High-performance liquid chromatography analytical method for N1,N1-diisopropyl ethylenediamine |
| CN109668975A (en) * | 2017-10-17 | 2019-04-23 | 齐鲁制药有限公司 | In relation to the detection method of substance in Ibandronate |
| CN110702819B (en) * | 2019-11-08 | 2022-09-06 | 浙江美测医药科技有限公司 | Method for separating and measuring polypeptide chiral isomers containing multiple chiral centers by using high performance liquid chromatography |
| CN114441681B (en) * | 2022-01-28 | 2024-06-04 | 山东省食品药品检验研究院 | Method for determining 20 free amino acids and L-hydroxyproline in special medical formula food |
| CN114965790B (en) * | 2022-06-13 | 2023-04-04 | 郑州大学第一附属医院 | Liquid phase detection method for amino acid impurities in lysine zinc gluconate particles |
| CN115453034B (en) * | 2022-09-19 | 2025-09-09 | 安徽普利药业有限公司 | Analysis method for chiral purity of amino acid and derivative thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6270759A (en) * | 1985-05-25 | 1987-04-01 | Shimadzu Corp | Blood anticonvulsant drug analysis method |
| JPS63124958A (en) * | 1986-11-14 | 1988-05-28 | Shimadzu Corp | Analysis method of aromatic amino acids using high performance liquid chromatography |
| CN1308233A (en) * | 2000-12-26 | 2001-08-15 | 姚绍斌 | Fast amino acid measuring method |
| CN1435691A (en) * | 2002-01-26 | 2003-08-13 | 中国科学院昆明动物研究所 | Method for determining amino acid in microdialysis sample by phenyl isothiocyanate derivatization method |
| EP1542017A1 (en) * | 2002-07-04 | 2005-06-15 | Mitsubishi Pharma Corporation | Method of examining and diagnosing integration dysfunction syndrome |
-
2005
- 2005-07-14 CN CNB2005100144780A patent/CN1320354C/en not_active Expired - Lifetime
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6270759A (en) * | 1985-05-25 | 1987-04-01 | Shimadzu Corp | Blood anticonvulsant drug analysis method |
| JPS63124958A (en) * | 1986-11-14 | 1988-05-28 | Shimadzu Corp | Analysis method of aromatic amino acids using high performance liquid chromatography |
| CN1308233A (en) * | 2000-12-26 | 2001-08-15 | 姚绍斌 | Fast amino acid measuring method |
| CN1435691A (en) * | 2002-01-26 | 2003-08-13 | 中国科学院昆明动物研究所 | Method for determining amino acid in microdialysis sample by phenyl isothiocyanate derivatization method |
| EP1542017A1 (en) * | 2002-07-04 | 2005-06-15 | Mitsubishi Pharma Corporation | Method of examining and diagnosing integration dysfunction syndrome |
Non-Patent Citations (5)
| Title |
|---|
| 柱前衍生高效液相色谱法测定食物中氨基酸含量 苗虹等,分析化学,第28卷第9期 2000 * |
| 注射用生长抑素中相关肽测定的研究 高恒莹等,首都医药,第7卷第10期 2000 * |
| 高效液相色谱中用于梯度洗脱的有机溶剂的纯度测试 邓华等,分析化学,第28卷第6期 2000 * |
| 高效液相色谱法测定羊水中兴奋性氨基酸、抑制性氨基酸的含量 李平等,分析化学,第33卷第6期 2005 * |
| 高效液相色谱法测定羊水中兴奋性氨基酸、抑制性氨基酸的含量 李平等,分析化学,第33卷第6期 2005;高效液相色谱中用于梯度洗脱的有机溶剂的纯度测试 邓华等,分析化学,第28卷第6期 2000;柱前衍生高效液相色谱法测定食物中氨基酸含量 苗虹等,分析化学,第28卷第9期 2000;注射用生长抑素中相关肽测定的研究 高恒莹等,首都医药,第7卷第10期 2000 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102702344A (en) * | 2012-06-14 | 2012-10-03 | 上海吉尔多肽有限公司 | Method for purifying tesamorelin |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1749748A (en) | 2006-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Camperi et al. | Multi-dimensional LC-MS: the next generation characterization of antibody-based therapeutics by unified online bottom-up, middle-up and intact approaches | |
| CN1320354C (en) | Method for analysizing amino acid | |
| Van Wandelen et al. | Using quaternary high-performance liquid chromatography eluent systems for separating 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-derivatized amino acid mixtures | |
| CN103713078B (en) | Amino acid whose assay method in a kind of honey | |
| Pucciarini et al. | Development and validation of a chiral UHPLC-MS method for the analysis of cysteine enantiomers in biological samples | |
| US8945933B2 (en) | Liquid chromatography-mass spectrometry methods for multiplexed detection and quantitation of free amino acids | |
| Liu et al. | Comprehensive N-glycan profiling of cetuximab biosimilar candidate by NP-HPLC and MALDI-MS | |
| Cao et al. | An automated and qualified platform method for site-specific succinimide and deamidation quantitation using low-pH peptide mapping | |
| Zhu et al. | A simultaneously quantitative profiling method for 40 endogenous amino acids and derivatives in cell lines using hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry | |
| CN101076727A (en) | Methods and systems for detection, identification and quantitation of macrolides and their impurities | |
| Bartolomé et al. | A fast method for analysing six perfluoroalkyl substances in human serum by solid-phase extraction on-line coupled to liquid chromatography tandem mass spectrometry | |
| Sha et al. | At-line N-linked glycan profiling for monoclonal antibodies with advanced sample preparation and high-performance liquid chromatography | |
| Oyaide et al. | Development of an off-line heart cutting two-dimensional HPLC system for enantioselective analysis of serine, threonine and allo-threonine in human physiological fluids | |
| CN107407668B (en) | Method and system for analyzing optical rotation of bound amino acid | |
| Sánchez-López et al. | Design of strategies to study the metabolic profile of highly polar compounds in plasma by reversed-phase liquid chromatography–high resolution mass spectrometry | |
| Ishii et al. | Development of a two-dimensional LC–MS/MS system for the determination of proline and 4-hydroxyproline enantiomers in biological and food samples | |
| Gao et al. | A novel fluorescent labeling reagent, 2-(9-acridone)-ethyl chloroformate, and its application to the analysis of free amino acids in honey samples by HPLC with fluorescence detection and identification with online ESI-MS | |
| Anderson | High-performance liquid chromatography in clinical analysis | |
| Hughes et al. | Amino acid analysis: protocols, possibilities, and pretensions | |
| Tamashima et al. | Direct tandem mass spectrometric analysis of amino acids in plasma using fluorous derivatization and monolithic solid-phase purification | |
| CN113834888B (en) | Accurate detection method and kit for 4 ceramides in blood | |
| CN113419007A (en) | Method for detecting target amino acid and creatinine in sample and detection kit thereof | |
| Alwael et al. | Development of a rapid and sensitive method for determination of cysteine/cystine ratio in chemically defined media | |
| CN101065664A (en) | Methods and systems for detection of macrolides | |
| CN1588007A (en) | Polysaccharide quantitative detecting method and system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Tianjin Tianan Pharmaceuticals Co.,Ltd. Assignor: Tianjin Pharmaceuticals Group Corp. Contract fulfillment period: 2009.6.30 to 2015.6.30 Contract record no.: 2009120000151 Denomination of invention: Method for analyzing sulphydryl amino acid by colorimetric detection Granted publication date: 20070606 License type: Exclusive license Record date: 20090731 |
|
| LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2009.6.30 TO 2015.6.30; CHANGE OF CONTRACT Name of requester: TIANJIN TIANAN MEDICINE INDUSTRY CO., LTD. Effective date: 20090731 |
|
| EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Tianjin Tianan Pharmaceuticals Co.,Ltd. Assignor: Tianjin Pharmaceuticals Group Corp. Contract record no.: 2009120000151 Date of cancellation: 20150409 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20060322 Assignee: TIANJIN JINYAO GROUP HUBEI TIANYAO PHARMACEUTICAL CO.,LTD. Assignor: Tianjin Pharmaceuticals Group Corp. Contract record no.: 2015120000019 Denomination of invention: Method for analyzing sulphydryl amino acid by colorimetric detection Granted publication date: 20070606 License type: Exclusive License Record date: 20150414 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| CP01 | Change in the name or title of a patent holder |
Address after: Cheng linzhuan Hedong District of Tianjin City Road 300161 No. 91 Patentee after: Tianjin Pharmaceutical Research Institute Co.,Ltd. Address before: Cheng linzhuan Hedong District of Tianjin City Road 300161 No. 91 Patentee before: TIANJIN PHARMACEUTICALS Group Corp. |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: 300457 Tianjin Binhai New Area Tianjin Development Zone West District Xinye Jiujie north, Xinhuan West Road East Patentee after: Tianjin Pharmaceutical Research Institute Co.,Ltd. Address before: Cheng linzhuan Hedong District of Tianjin City Road 300161 No. 91 Patentee before: Tianjin Pharmaceutical Research Institute Co.,Ltd. |
|
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: 300457 North Xinye 9th Street and East Xinhuan West Road, West District, Binhai New Area Development Zone, Tianjin Patentee after: Tianjin Pharmaceutical Research Institute Co.,Ltd. Address before: 300457 Tianjin Binhai New Area Tianjin Development Zone West District Xinye Jiujie north, Xinhuan West Road East Patentee before: Tianjin Pharmaceutical Research Institute Co.,Ltd. |
|
| CP02 | Change in the address of a patent holder | ||
| CX01 | Expiry of patent term |
Granted publication date: 20070606 |
|
| CX01 | Expiry of patent term |